Further, TNS3 interacts with AD-related druggable genes EGF and HGF, which in turn interact with EGFR (eFigure-11), a gene that was recently implicated in Alzheimer’s disease through GWAS15 and itself shows strong potential as a dual drug target for cancer and AD68. This evidence concerns the gene HGF and early-onset autosomal dominant Alzheimer disease.